Literature DB >> 25865691

Preoperative serum liver enzyme markers for predicting early recurrence after curative resection of hepatocellular carcinoma.

Zhong-Xia Wang1, Chun-Ping Jiang, Yin Cao, Guang Zhang, Wei-Bo Chen, Yi-Tao Ding.   

Abstract

BACKGROUND: Early recurrence of hepatocellular carcinoma (HCC) is associated with worse prognosis after liver resection. This study aimed to investigate the prognostic value of common liver enzyme markers in HCC early recurrence after curative hepatectomy and to establish a simple predictive model for HCC early recurrence.
METHODS: A total of 200 patients who had undergone curative resection for HCC were retrospectively analyzed. The patients were divided into early recurrence (within 2 years) and non-early recurrence groups. Demographical characteristics, preoperative liver function parameters, surgical factors and tumor related factors of the patients were assessed by univariate analysis to identify potential significant predictors for early recurrence after resection of HCC. Parameters with statistical significance were entered into a Cox proportional hazard model to find independent risk factors. Receiver operating characteristic analysis was done to determine optimal cut-off values and the number of combined factors in multi-factor predictive model.
RESULTS: Of 13 potential risk factors for early recurrence identified by univariate analysis, high lactate dehydrogenase (LDH>206 U/L, HR=1.711, P=0.006), high aspartate aminotransferase (AST)/alanine aminotransferase (ALT) ratio (AST/ALT>0.96, HR=1.769, P=0.006), elevated alpha-fetoprotein (AFP<8.6 ng/mL, HR=2.079, P=0.007), small resection margin (≤1 cm, HR=2.354, P<0.001) and advanced TNM stage (TNM III-IV, HR=2.164, P<0.001) were independent risk factors for early recurrence of HCC shown by multivariate analysis. Patients with three or more concurrent independent risk factors had significantly higher risk for early recurrence than those with low risk factors. The sensitivity and specificity of this predictive model are 53.6% and 80.7%, respectively (area under curve=0.741, 95% CI 0.674-0.800, P<0.0001).
CONCLUSIONS: Preoperative common liver enzyme markers, LDH and AST/ALT ratio, were independently associated with early recurrence of HCC. The combination of serum liver enzyme markers with AFP, resection margin and TNM stage better predicted early recurrence of HCC after curative resection in a simple multi-factor model.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25865691     DOI: 10.1016/s1499-3872(15)60353-8

Source DB:  PubMed          Journal:  Hepatobiliary Pancreat Dis Int


  13 in total

1.  Gadoxetic acid-enhanced MRI radiomics signature: prediction of clinical outcome in hepatocellular carcinoma after surgical resection.

Authors:  Zhen Zhang; Jie Chen; Hanyu Jiang; Yi Wei; Xin Zhang; Likun Cao; Ting Duan; Zheng Ye; Shan Yao; Xuelin Pan; Bin Song
Journal:  Ann Transl Med       Date:  2020-07

Review 2.  Dysregulation of immune checkpoint proteins in hepatocellular carcinoma: Impact on metabolic reprogramming.

Authors:  Kanchan Vishnoi; Sandeep Kumar; Rong Ke; Ajay Rana; Basabi Rana
Journal:  Curr Opin Pharmacol       Date:  2022-05-05       Impact factor: 4.768

Review 3.  Liver transplantation for hepatocellular carcinoma - factors influencing outcome and disease-free survival.

Authors:  René Fahrner; Felix Dondorf; Michael Ardelt; Yves Dittmar; Utz Settmacher; Falk Rauchfuß
Journal:  World J Gastroenterol       Date:  2015-11-14       Impact factor: 5.742

Review 4.  Reprogramming of glucose metabolism in hepatocellular carcinoma: Progress and prospects.

Authors:  Run-Ze Shang; Shi-Bin Qu; De-Sheng Wang
Journal:  World J Gastroenterol       Date:  2016-12-07       Impact factor: 5.742

5.  Neutrophil-to-lymphocyte and aspartate-to-alanine aminotransferase ratios predict hepatocellular carcinoma prognosis after transarterial embolization.

Authors:  Chang Liu; Bang-Sheng Jia; Bing-Wen Zou; Hua Du; Lu-Nan Yan; Jia-Yin Yang; Li Jiang; Tian-Fu Wen; Wu-Sheng Lu
Journal:  Medicine (Baltimore)       Date:  2017-11       Impact factor: 1.817

Review 6.  Lactate Dehydrogenase in Hepatocellular Carcinoma: Something Old, Something New.

Authors:  Luca Faloppi; Maristella Bianconi; Riccardo Memeo; Andrea Casadei Gardini; Riccardo Giampieri; Alessandro Bittoni; Kalliopi Andrikou; Michela Del Prete; Stefano Cascinu; Mario Scartozzi
Journal:  Biomed Res Int       Date:  2016-05-29       Impact factor: 3.411

7.  The effect of AST/ALT (De Ritis) ratio on survival and its relation to tumor histopathological variables in patients with localized renal cell carcinoma.

Authors:  Lütfi Canat; Hasan Anil Ataly; Samir Agalarov; Ilter Alkan; Fatih Altunrende
Journal:  Int Braz J Urol       Date:  2018 Mar-Apr       Impact factor: 1.541

8.  Prognostic Value of Lactate Dehydrogenase in Patients with Hepatocellular Carcinoma: A Meta-Analysis.

Authors:  Weihao Kong; Xiaomin Zuo; Hao Liang; Jingxiong Hu; Huabing Zhang; Xingyu Wang; Wei Chen
Journal:  Biomed Res Int       Date:  2018-12-27       Impact factor: 3.411

9.  Novel Prognostic Scores Based on Plasma Prothrombin Time and Fibrinogen Levels in Patients With AFP-Negative Hepatocellular Carcinoma.

Authors:  Minjie Mao; Xueping Wang; Yiling Song; Hui Sheng; Runkun Han; Weihong Lin; Shuqin Dai
Journal:  Cancer Control       Date:  2020 Jan-Dec       Impact factor: 3.302

10.  Diagnostic value of gamma-glutamyl transpeptidase to alkaline phosphatase ratio combined with gamma-glutamyl transpeptidase to aspartate aminotransferase ratio and alanine aminotransferase to aspartate aminotransferase ratio in alpha-fetoprotein-negative hepatocellular carcinoma.

Authors:  Jiang Li; Haisu Tao; Erlei Zhang; Zhiyong Huang
Journal:  Cancer Med       Date:  2021-06-18       Impact factor: 4.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.